52 Week HighDivis Labs has hit a 52wk high of Rs 1,452.35 on NSE
52 Week HighDivis Labs has hit a 52wk high of Rs 1,445.00 on BSE
52 Week HighDivis Labs has hit a 52wk high of Rs 1,435.00 on BSE
52 Week HighDivis Labs has hit a 52wk high of Rs 1,430.00 on BSE
100% of moneycontrol users recommend selling Divis Labs.
What's your call on Divis Labs today?
Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||2565.45||0.50||2939.80||1999.40||43,640.58|
|Mar' 14||Dec' 13||Sep' 13||Jun' 13|
|Scheme||No. of Shares|
|Reliance Equity Opportunities Fund - Retail Plan (G)||2,530,929|
|Reliance Growth Fund - Retail Plan (G)||1,424,273|
|Reliance Regular Savings Fund - Equity Option (G)||768,404|
|Reliance Pharma Fund (G)||628,544|
Divis Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 18,152.74 crore.The company has reported a standalone sales of Rs 687.41 crore and a Net Profit of Rs 219.02 crore for the quarter ended Dec 2013.
The company management includes Murali K Divi - Chairman & Managing Director, N V Ramana - Executive Director, Madhusudana Rao Divi - Director - Projects, Kiran S Divi - President & Director, K Satyanarayana - Director, S Vasudev - Director, G Suresh Kumar - Director.
It is listed on the BSE with a BSE Code of 532488 and the NSE with an NSE Code of DIVISLAB.
Its Registered office is at 7-1-77/E/1/303, Divi Towers,,Dharam Karan Road, Hyderabad,Andhra Pradesh - 500016.
Their Registrars are Karvy Computershare Private Ltd.